Aurrigo International PLC
LSE:AURR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aurrigo International PLC
LSE:AURR
|
UK |
|
Sichuan Huiyu Pharmaceutical Co Ltd
SSE:688553
|
CN |
|
Five9 Inc
NASDAQ:FIVN
|
US |
|
HB Fuller Co
NYSE:FUL
|
US |
|
Lupatech SA
BOVESPA:LUPA3
|
BR |
|
Westgold Resources Ltd
ASX:WGX
|
AU |
|
B
|
Bahnhof AB (publ)
STO:BAHN B
|
SE |
|
E
|
ESAB Corp
NYSE:ESAB
|
US |
|
J
|
Joincare Pharmaceutical Group Industry Co Ltd
SSE:600380
|
CN |
|
China New Town Development Co Ltd
HKEX:1278
|
HK |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
ID |
|
P
|
Purmo Group Oyj
OMXH:PURMO
|
FI |
|
eBASE Co Ltd
TSE:3835
|
JP |
|
I
|
IP Rings Ltd
BSE:523638
|
IN |
|
X
|
X Fab Silicon Foundries EV
OTC:XFABF
|
BE |
|
G
|
Gujarat Intrux Ltd
BSE:517372
|
IN |
|
L
|
Lypsa Gems & Jewellery Ltd
NSE:LYPSAGEMS
|
IN |
|
T
|
Tencent Holdings Ltd
OTC:TCTZF
|
CN |
|
P
|
Pure Gold Mining Inc
LSE:PUR
|
CA |
|
Ktis Corp
KRX:058860
|
KR |
Balance Sheet
Balance Sheet Decomposition
Aurrigo International PLC
Aurrigo International PLC
Balance Sheet
Aurrigo International PLC
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
1
|
2
|
1
|
5
|
3
|
3
|
|
| Cash Equivalents |
1
|
2
|
1
|
5
|
3
|
3
|
|
| Total Receivables |
2
|
1
|
1
|
2
|
2
|
2
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
1
|
1
|
1
|
2
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
4
|
4
|
4
|
8
|
8
|
7
|
|
| PP&E Net |
1
|
0
|
0
|
0
|
1
|
2
|
|
| PP&E Gross |
1
|
0
|
0
|
0
|
1
|
2
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
2
|
3
|
4
|
5
|
6
|
6
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
6
N/A
|
7
+12%
|
8
+15%
|
14
+68%
|
15
+7%
|
16
+9%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
2
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
2
|
3
|
3
|
3
|
3
|
|
| Total Liabilities |
3
N/A
|
4
+32%
|
5
+30%
|
5
+9%
|
6
+15%
|
6
+6%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
4
|
4
|
1
|
2
|
4
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
7
|
11
|
14
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
4
-3%
|
4
-1%
|
9
+145%
|
9
+3%
|
10
+10%
|
|
| Total Liabilities & Equity |
6
N/A
|
7
+12%
|
8
+15%
|
14
+68%
|
15
+7%
|
16
+9%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
42
|
42
|
42
|
42
|
46
|
54
|
|